Farther Finance Advisors, LLC Horizon Therapeutics Public LTD CO Transaction History

Farther Finance Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	N/A	-1,028 Closed	0 $0
Q3 2023 Nov 13, 2023	BUY	$98.98 - $115.74 $1,286 - $1,504	13 Added 1.26%	1,041 $120 Million
Q2 2023 May 13, 2024	SELL	$96.34 - $112.38 $96 - $112	-1 Reduced 0.1%	1,028 $106 Million
Q2 2023 Sep 12, 2023	SELL	$96.34 - $112.38 $96 - $112	-1 Reduced 0.1%	1,028 $106 Million
Q1 2023 May 13, 2024	BUY	$107.32 - $113.5 $110,432 - $116,791	1,029 New	1,029 $112 Million
Q1 2023 Sep 12, 2023	BUY	$107.32 - $113.5 $536 - $567	5 Added 0.49%	1,029 $112 Million
Q4 2022 Sep 11, 2023	BUY	$62.39 - $113.8 $63,887 - $116,531	1,024 New	1,024 $117 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Farther Finance Advisors, LLC with notifications on news.